General MedicationsINJECTIONStandard
ACTHREL
CORTICORELIN OVINE TRIFLUTATE
Standard Dose
EQ 0.1MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: 901 REQUIRED Marketing status: Prescription
Summary
Approval overview ACTHREL is listed in Drugs@FDA under application 020162 (BLA).
Review priority: 901 REQUIRED Marketing status: Prescription Active ingredient CORTICORELIN OVINE TRIFLUTATE Form and strength INJECTABLE;INJECTION - EQ 0.1MG BASE/VIAL Sponsor FERRING Submission history Latest submission status date: 2015-09-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview ACTHREL is listed in Drugs@FDA under application 020162 (BLA). Review priority: 901 REQUIRED Marketing status: Prescription Active ingredient CORTICORELIN OVINE TRIFLUTATE Form and strength INJECTABLE;INJECTION - EQ 0.1MG BASE/VIAL Sponsor FERRING Submission history Latest submission status date: 2015-09-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: 901 REQUIRED
Interaction Notes
- No interaction notes stored yet.